• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Antiviral Therapy for HPAI and Reported Oseltamivir Resistance in Canada.加拿大高致病性禽流感的抗病毒治疗及报告的奥司他韦耐药性
J Assoc Med Microbiol Infect Dis Can. 2025 Jun 27;10(2):101-104. doi: 10.3138/jammi-2025-0307. eCollection 2025 Jun.
2
Antiviral therapy for influenza in high-risk outpatients: a multicenter observational study of routine clinical practice in Russia.高危门诊患者流感的抗病毒治疗：俄罗斯常规临床实践的多中心观察性研究
Ther Adv Infect Dis. 2025 Jun 20;12:20499361251347726. doi: 10.1177/20499361251347726. eCollection 2025 Jan-Dec.
3
Systematic review of influenza resistance to the neuraminidase inhibitors.抗流感神经氨酸酶抑制剂耐药性的系统评价。
BMC Infect Dis. 2011 May 19;11:134. doi: 10.1186/1471-2334-11-134.
4
Assessing the susceptibility of highly pathogenic avian influenza H5N1 viruses to oseltamivir using embryonated chicken eggs.用鸡胚评估高致病性禽流感 H5N1 病毒对奥司他韦的敏感性。
Indian J Med Res. 2019 Nov;150(5):486-491. doi: 10.4103/ijmr.IJMR_845_18.
5
Highly pathogenic avian influenza H7N9 viruses with reduced susceptibility to neuraminidase inhibitors showed comparable replication capacity to their sensitive counterparts.高致病性禽流感 H7N9 病毒对神经氨酸酶抑制剂的敏感性降低，其复制能力与敏感病毒相当。
Virol J. 2019 Jul 2;16(1):87. doi: 10.1186/s12985-019-1194-9.
6
Neuraminidase inhibitors for preventing and treating influenza in healthy adults.用于预防和治疗健康成年人流感的神经氨酸酶抑制剂。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD001265. doi: 10.1002/14651858.CD001265.pub2.
7
Antiviral efficacy of oseltamivir against avian influenza virus in avian species.奥司他韦对禽类中禽流感病毒的抗病毒效力
Avian Dis. 2011 Dec;55(4):677-9. doi: 10.1637/9725-031811-ResNote.1.
8
Antivirals for post-exposure prophylaxis of influenza: a systematic review and network meta-analysis.抗流感病毒药物用于暴露后预防：系统评价和网络荟萃分析。
Lancet. 2024 Aug 24;404(10454):764-772. doi: 10.1016/S0140-6736(24)01357-6.
9
Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.抗流感病毒药物治疗严重流感：一项随机对照试验的系统评价和网络荟萃分析。
Lancet. 2024 Aug 24;404(10454):753-763. doi: 10.1016/S0140-6736(24)01307-2.
10
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.抗流感病毒药物治疗：观察性研究的系统评价和荟萃分析。
Ann Intern Med. 2012 Apr 3;156(7):512-24. doi: 10.7326/0003-4819-156-7-201204030-00411. Epub 2012 Feb 27.

本文引用的文献

1
Neuraminidase reassortment and oseltamivir resistance in clade 2.3.4.4b A(H5N1) viruses circulating among Canadian poultry, 2024.2024年在加拿大禽类中传播的2.3.4.4b分支A(H5N1)病毒中的神经氨酸酶重配和对奥司他韦的耐药性
Emerg Microbes Infect. 2025 Dec;14(1):2469643. doi: 10.1080/22221751.2025.2469643. Epub 2025 Mar 11.
2
Highly Pathogenic Avian Influenza A(H5N1) Virus Infections in Humans.人类感染高致病性甲型流感病毒（H5N1）
N Engl J Med. 2025 Feb 27;392(9):843-854. doi: 10.1056/NEJMoa2414610. Epub 2024 Dec 31.
3
Critical Illness in an Adolescent with Influenza A(H5N1) Virus Infection.一名感染甲型H5N1流感病毒青少年的危重症情况
N Engl J Med. 2025 Feb 27;392(9):927-929. doi: 10.1056/NEJMc2415890. Epub 2024 Dec 31.
4
Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials.抗流感病毒药物治疗严重流感：一项随机对照试验的系统评价和网络荟萃分析。
Lancet. 2024 Aug 24;404(10454):753-763. doi: 10.1016/S0140-6736(24)01307-2.
5
Multiple transatlantic incursions of highly pathogenic avian influenza clade 2.3.4.4b A(H5N5) virus into North America and spillover to mammals.高致病性禽流感 clade 2.3.4.4b 亚型（H5N5）病毒多次跨越大西洋传入北美洲，并溢出到哺乳动物。
Cell Rep. 2024 Jul 23;43(7):114479. doi: 10.1016/j.celrep.2024.114479. Epub 2024 Jul 13.
6
Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022-2023 influenza season in Japan.在日本2022 - 2023年流感季节期间，巴洛沙韦酯治疗前后对具有聚合酶酸性亚基替代的甲型（H3N2）流感病毒的检测。
Antiviral Res. 2024 Sep;229:105956. doi: 10.1016/j.antiviral.2024.105956. Epub 2024 Jul 4.
7
Highly Pathogenic Avian Influenza A(H5N1) Clade 2.3.4.4b Virus Infection in Domestic Dairy Cattle and Cats, United States, 2024.美国 2024 年家养奶牛和猫感染高致病性禽流感 A(H5N1) 病毒 2.3.4.4b 分支
Emerg Infect Dis. 2024 Jul;30(7):1335-1343. doi: 10.3201/eid3007.240508. Epub 2024 Apr 29.
8
Baloxavir marboxil use for critical human infection of avian influenza A H5N6 virus.巴洛沙韦马立克韦用于治疗人感染高致病性禽流感病毒 H5N6 危重症。
Med. 2024 Jan 12;5(1):32-41.e5. doi: 10.1016/j.medj.2023.11.001. Epub 2023 Dec 8.
9
AMMI Canada 2023 update on influenza: Management and emerging issues.加拿大AMMI 2023年流感最新情况：管理与新出现的问题
J Assoc Med Microbiol Infect Dis Can. 2023 Nov 29;8(3):176-185. doi: 10.3138/jammi-2023-07-12. eCollection 2023 Nov.
10
Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.2022 - 2023年全球流行的高致病性甲型禽流感病毒（H5N1）的抗病毒敏感性
J Infect Dis. 2024 Jun 14;229(6):1830-1835. doi: 10.1093/infdis/jiad418.

Antiviral Therapy for HPAI and Reported Oseltamivir Resistance in Canada.

作者信息

Mubareka Samira, Papenburg Jesse, Harrison Robyn, Allen Upton, Skowronski Danuta M, Hatchette Todd F, Evans Gerald A

机构信息

Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre.

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

出版信息

J Assoc Med Microbiol Infect Dis Can. 2025 Jun 27;10(2):101-104. doi: 10.3138/jammi-2025-0307. eCollection 2025 Jun.

DOI:10.3138/jammi-2025-0307
PMID:40673056
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12253934/
Abstract
摘要